Brief: iRhythm Technologies Under License Agreement with Biointellisense, To Pay Biois Upfront Fee Of $15 Mln In Cash
Sept 4 (Reuters) - iRhythm Technologies Inc IRTC.O :
* IRHYTHM TECHNOLOGIES : UNDER LICENSE AGREEMENTWITH
BIOINTELLISENSE, TO PAY BIOIS UPFRONT FEE OF $15.0 MILLION IN
CASH
* IRHYTHM : TO PAY BIOIS UPFRONT FEE OF $15.0 MILLION IN
CASH UPON
CO'S ACCEPTANCE OF INITIAL TRANSFER OF CERTAIN DATA POST
EXECUTION OF DEAL
Source text for Eikon: ID:n0001388658-24-000156
Further company coverage: IRTC.O
((Reuters.Brief@thomsonreuters.com))
Recent news on iRhythm Holdings
See all newsiRhythm Holdings, Inc reports results for the quarter ended September 30 - Earnings Summary
iRhythm Q3 revenue slightly misses estimates; net loss widens YoY
Brief: iRhythm Holdings Q3 Revenue USD 221.6 Million Vs. IBES Estimate USD 222.5 Million
Brief: Irhythm Provides Update On Cybersecurity Incident Previously Disclosed In June 2026
Factbox: US companies face rise in cyber attacks